Table 1.
Demographics, comorbidities, and CRC screening knowledge, attitudes, and beliefs of respondents who completed Surveys 1 (without description of need for colonoscopy after + FIT) and 2 (with description).
| Variable |
Survey 1: without description (n = 501) |
Survey 2: with description (n = 1,000) |
P-value |
|---|---|---|---|
| Age: | 0.04 | ||
| 40–49 yo | 194 (38.7%) | 456 (45.6%) | |
| 50–59 yo | 146 (29.1%) | 267 (26.7%) | |
| ≥60 yo | 161 (32.1%) | 277 (27.7%) | |
| Sex: | 0.45 | ||
| Male | 256 (51.1%) | 487 (48.7%) | |
| Female | 244 (48.7%) | 512 (51.2%) | |
| Prefer not to say | 1 (0.2%) | 1 (0.1%) | |
| Race/ethnicity: | 0.33 | ||
| Non-Hispanic White | 389 (77.6%) | 806 (80.6%) | |
| Non-Hispanic Black | 27 (5.4%) | 64 (6.4%) | |
| Hispanic | 37 (7.4%) | 57 (5.7%) | |
| Non-Hispanic Asian | 26 (5.2%) | 41 (4.1%) | |
| Other | 22 (4.4%) | 32 (3.2%) | |
| Educational attainment: | 0.94 | ||
| High school degree or less | 140 (27.9%) | 281 (28.1%) | |
| Some college education | 128 (25.5%) | 248 (24.8%) | |
| College degree | 167 (33.3%) | 347 (34.7%) | |
| Graduate degree | 66 (13.2%) | 124 (12.4%) | |
| Marital status: | 0.94 | ||
| Married or living with a partner | 266 (53.1%) | 529 (52.9%) | |
| Not married | 235 (46.9%) | 471 (47.1%) | |
| Total household income, $: | 0.006 | ||
| <50,000 | 244 (48.7%) | 517 (51.7%) | |
| 50,000–100,000 | 146 (29.1%) | 298 (29.8%) | |
| ≥100,001 | 81 (16.2%) | 161 (16.1%) | |
| Prefer not to say | 30 (6.0%) | 24 (2.4%) | |
| Employment status: | 0.34 | ||
| Unemployed, on disability, on leave of absence from work, retired, or a homemaker | 249 (49.7%) | 471 (47.1%) | |
| Employed or student | 252 (50.3%) | 529 (52.9%) | |
| Has health insurance | 418 (83.4%) | 845 (84.5%) | 0.59 |
| Has usual source of care | 379 (75.6%) | 800 (80.0%) | 0.05 |
| Self-reported health status: | 0.34 | ||
| Excellent | 57 (11.4%) | 88 (8.8%) | |
| Very good | 130 (25.9%) | 280 (28.0%) | |
| Good | 210 (41.9%) | 407 (40.7%) | |
| Fair/Poor | 104 (20.8%) | 225 (22.5%) | |
| Number of medical comorbidities a: | 0.008 | ||
| 0 | 156 (31.1%) | 252 (25.2%) | |
| 1 | 124 (24.8%) | 225 (22.5%) | |
| ≥2 | 221 (44.1%) | 523 (52.3%) | |
| Number of GI comorbidities b: | 0.02 | ||
| 0 | 412 (82.2%) | 760 (76.0%) | |
| 1 | 62 (12.4%) | 170 (17.0%) | |
| ≥2 | 27 (5.4%) | 70 (7.0%) | |
| Number of GI symptoms experienced in past 3 months c: | 0.02 | ||
| 0 | 279 (55.7%) | 479 (47.9%) | |
| 1 | 87 (17.4%) | 202 (20.2%) | |
| ≥2 | 135 (26.9%) | 319 (31.9%) | |
| US region: | 0.15 | ||
| Northeast | 89 (17.8%) | 225 (22.5%) | |
| South | 174 (34.7%) | 344 (34.4%) | |
| Midwest | 119 (23.8%) | 207 (20.7%) | |
| West | 119 (23.8%) | 224 (22.4%) | |
| Plans to get screened for CRC | 243 (48.5%) | 519 (51.9%) | 0.21 |
| Has non-first degree relative or friend diagnosed with CRC | 59 (11.8%) | 138 (13.8%) | 0.27 |
| Self-perceived CRC susceptibility (1–5 scale; higher = more susceptible) |
2.6 [1.8, 3.0] | 2.6 [2.0, 3.0] | 0.91 |
| Self-perceived impact of CRC diagnosis (1–5 scale; higher = more severe impact) |
3.1 [2.8, 3.6] | 3.2 [2.8, 3.7] | 0.06 |
| Self-perceived benefits of CRC screening (1–5 scale; higher = more beneficial) |
4.0 [3.6, 4.4] | 4.0 [3.6, 4.4] | 0.55 |
| Self-perceived barriers to CRC screening (1–5 scale; higher = more barriers) |
2.7 [2.3, 3.1] | 2.7 [2.3, 3.1] | 0.60 |
| Data are presented as n (% of column) or median [interquartile range]. P-values were computed using Pearson’s chi-squared test, Fisher’s exact test, or Student’s t-test. CRC, colorectal cancer; FIT, fecal immunochemical test; GI, gastrointestinal. a: Includes anemia or other blood disease, back pain, cancer, depression, diabetes, heart disease, high blood pressure, kidney disease, lung disease, migraines, osteoarthritis or degenerative arthritis, rheumatoid arthritis, or other medical problems. b: Includes celiac disease, cirrhosis, diverticulitis, gallstones, gastroenteritis, gastroesophageal reflux disease, gastroparesis, irritable bowel syndrome, liver disease, pancreatitis, or ulcer or stomach disease. c: Includes abdominal pain or discomfort, anal or rectal pain, bloating, bowel incontinence, constipation, diarrhea, dysphagia, heartburn, nausea/vomiting, or regurgitation. | |||